Certain Philips Respironics Trilogy Ventilators See Another Class I Recall

The FDA has classified the most recent recall of certain Philips Trilogy ventilators as class I, the most serious type of recall as use of the device may lead to serious injury or death.

This recall is for 73,000 Philips Respironics Trilogy Evo, Trilogy Evo O2, Trilogy EV300 and Trilogy Evo Universal ventilators. These devices provide continuous positive airway pressure (CPAP) and intermittent positive airway pressure breathing support for people who need mechanical ventilation. The company first initiated the recall on March 29.

Philips is recalling the ventilators after detecting dust and dirt from the environment in the air path of some devices. Dust and dirt can lead to buildup that may block air vents and cause the device to stop delivering the right amount of air pressure, or air volume/flow and patients may then may not receive enough oxygen.

To read the full story, click here to subscribe.

Related Topics